Pardeep Nijhawan Edesa Biotech, Inc. (EDSA) insider trading activity

EDSA Quotes by TradingView

Pardeep Nijhawan is Chief Executive Officer of Edesa Biotech, Inc.. Currently has a direct ownership of 132,618 shares of EDSA, which is worth approximately $327,566. The most recent transaction as insider was on Oct 02, 2024, when has been sold 3,300 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K
5.03% 3M change
80.89% 12M change
Total Value Held $327,566

Pardeep Nijhawan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2024
BUY
Grant, award, or other acquisition
-
3,300 Added 2.43%
132,618 Common Shares
Sep 03 2024
BUY
Grant, award, or other acquisition
-
3,055 Added 2.31%
129,318 Common Shares
Aug 01 2024
BUY
Grant, award, or other acquisition
-
3,317 Added 2.56%
126,263 Common Shares
Jul 02 2024
BUY
Grant, award, or other acquisition
-
4,015 Added 3.16%
122,946 Common Shares
Jun 03 2024
BUY
Grant, award, or other acquisition
-
4,785 Added 3.87%
118,931 Common Shares
May 01 2024
BUY
Grant, award, or other acquisition
-
3,083 Added 2.63%
114,146 Common Share
Apr 01 2024
BUY
Grant, award, or other acquisition
-
3,253 Added 2.85%
111,063 Common Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
2,765 Added 2.5%
107,810 Common Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
2,978 Added 2.76%
105,045 Common Shares
Jan 08 2024
BUY
Grant, award, or other acquisition
-
2,908 Added 2.77%
102,067 Common Shares
Aug 04 2023
BUY
Grant, award, or other acquisition
-
99,300 Added 12.52%
694,112 Common Shares
Jun 30 2022
BUY
Open market or private purchase
$32,000 $1.6 p/Share
20,000 Added 3.25%
594,812 Common Shares
May 27 2022
BUY
Open market or private purchase
$9,600 $1.92 p/Share
5,000 Added 0.86%
574,812 Common Shares
May 24 2022
BUY
Open market or private purchase
$3,600 $1.8 p/Share
2,000 Added 0.35%
569,812 Common Shares
Mar 31 2022
BUY
Open market or private purchase
$5,980 $2.99 p/Share
2,000 Added 0.35%
567,812 Common Shares
Mar 30 2022
BUY
Open market or private purchase
$6,100 $3.05 p/Share
2,000 Added 0.35%
565,812 Common Shares
Mar 29 2022
BUY
Open market or private purchase
$6,040 $3.02 p/Share
2,000 Added 0.35%
563,812 Common Shares
Mar 18 2022
BUY
Open market or private purchase
$7,700 $3.85 p/Share
2,000 Added 0.35%
561,812 Common Shares
Mar 17 2022
BUY
Open market or private purchase
$6,520 $3.26 p/Share
2,000 Added 0.36%
559,812 Common Shares
Mar 15 2022
BUY
Open market or private purchase
$5,600 $2.8 p/Share
2,000 Added 0.36%
557,812 Common Shares
Mar 11 2022
BUY
Open market or private purchase
$21,840 $3.12 p/Share
7,000 Added 1.24%
555,812 Common Shares
Mar 09 2022
BUY
Open market or private purchase
$4,575 $3.05 p/Share
1,500 Added 0.27%
548,812 Common Shares
Mar 25 2021
BUY
Open market or private purchase
$15,750 $5.25 p/Share
3,000 Added 0.55%
545,312 Common Shares
Mar 24 2021
BUY
Open market or private purchase
$25,800 $5.16 p/Share
5,000 Added 0.91%
542,312 Common Shares
Mar 29 2020
BUY
Open market or private purchase
$10,460 $5.23 p/Share
2,000 Added 0.36%
547,312 Common Shares
PN

Pardeep Nijhawan

Chief Executive Officer
Markham, A6

Track Institutional and Insider Activities on EDSA

Follow Edesa Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDSA shares.

Notify only if

Insider Trading

Get notified when an Edesa Biotech, Inc. insider buys or sells EDSA shares.

Notify only if

News

Receive news related to Edesa Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EDSA